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HyperoxiaThe measurement of venous cerebral blood oxygenation (Yv) has potential applications in the study of patient
groups where oxygen extraction and/or metabolism are compromised. It is also useful for fMRI studies to assess
the stimulus-induced changes in Yv, particularly since basal Yv partially accounts for inter-subject variation in the
haemodynamic response to a stimulus. A range of MRI-basedmethods of measuring Yv have been developed re-
cently. Here, we use a method based on the change in phase in the MR image arising from the ﬁeld perturbation
caused by deoxygenatedhaemoglobin in veins.Webuild on the existing phase based approach (Method I),where
Yv is measured in a large vein (such as the superior sagittal sinus) based on the ﬁeld shift inside the veinwith as-
sumptions as to the vein's shape and orientation. We demonstrate two novel modiﬁcations which address limi-
tations of this method. The ﬁrst modiﬁcation (Method II), maps the actual form of the vein, rather than assume a
given shape and orientation. The secondmodiﬁcation (Method III) uses the intra andperivascular phase change in
response to a known change in Yv on hyperoxia to measure normoxic Yv in smaller veins.Method III can be ap-
plied to veins whose shape, size and orientation are not accurately known, thus allowing more localised mea-
sures of venous oxygenation. Results demonstrate that the use of an overly ﬁne spatial ﬁlter caused an
overestimation in Yv for Method I, whilst the measurement of Yv usingMethod IIwas less sensitive to this bias,
giving Yv= 0.62± 0.03.Method IIIwas applied tomapping of Yv in local veins across the brain, yielding a distri-
bution of values with a mode of Yv = 0.661 ± 0.008.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).Introduction
Venous cerebral blood oxygenation (Yv) is the haemoglobin oxygen
saturation fraction in venous blood. The combination of in-vivo, non-
invasive, MRI-based measurements of Yv with other MR measures pro-
vides important haemodynamic information. For example, ameasure of
Yv is required for hyperoxia-based calibrated blood oxygen-level depen-
dent (BOLD) experiments as ameasured (rather than assumed) value of
basal oxygen extraction fraction (OEF) is preferred (Chiarelli et al.,
2007; Driver et al., 2012), basal Yv measurements can be combined
with phase contrastMRImeasures of cerebral bloodﬂow (CBF) to calcu-
late cerebral oxygen metabolism (Xu et al., 2009; Jain et al., 2010), and
measures of Yv have been used to explain inter-subject variability in
fMRI results (Lu et al., 2008). The assessment of Yv also has potential
use in studying conditions where oxygen extraction is thought to be
compromised, such as multiple sclerosis (Ge et al., 2012), traumatic
brain injury (Shen et al., 2007) and carotid stenosis (Kavec et al., 2004).ic Resonance Centre, University
. Fax: +44 1159515166.
.A. Gowland).
. This is an open access article underMR-susceptometry-based measurements of Yv estimate the suscep-
tibility shift between a blood vessel and the surrounding tissue from
phase maps, thus making such methods relatively simple and quick to
implement. Whilst fully oxygenated blood has a similar magnetic sus-
ceptibility to the surrounding tissue, the susceptibility of deoxygenated
haemoglobin (dHb) is sufﬁciently different to cause a ﬁeld perturbation.
This ﬁeld perturbation results in a phase shift, the value of which de-
pends on the amount of dHb and the orientation of the blood vessel.
The magnetic susceptibility difference can be measured from this
phase shift and hence Yv can be estimated, assuming a value for
haematocrit (Hct).
The most commonly used MR-susceptometry technique (Haacke
et al., 1997; Fernandez-Seara et al., 2006; Jain et al., 2010; Fan et al.,
2012) uses the intravascular phase shift arising from a long, straight
vein, orientated approximately parallel to the direction of the static
magnetic ﬁeld (B0). If a vein is straight over a length much greater
than its diameter, the ﬁeld perturbation in and around it can be
modelled as if it is an inﬁnite cylinder; this approximation has been val-
idated for MR-susceptometry in the superior sagittal sinus and jugular
vein (Li et al., 2012). When the inﬁnite cylinder approximation applies,
the phasewithin the vein will be homogeneous, with an amplitude that
depends on both the amount of dHb (and so Yv) and the vein'sthe CC BY license (http://creativecommons.org/licenses/by/3.0/).
459I.D. Driver et al. / NeuroImage 101 (2014) 458–465orientation to B0 (maximum where the vein is parallel to B0). The local
extravascular phase variation will be maximum where the vein is per-
pendicular to B0 and zero where the vein is parallel to B0 (Boxerman
et al., 1995).
The approach generally used to estimate Yv is to select a long, straight
vein, orientated approximately parallel to B0, such that the inﬁnite cylin-
der approximation applies (Haacke et al., 1997; Fernandez-Seara et al.,
2006; Jain et al., 2010). The chosen vein also needs to be sufﬁciently
large such that an intravascular region free from partial volume effects
can be selected to avoid diluting the estimatedYv. Therefore this approach
yields a global measure of Yv, limited to a small number of large veins,
eachdraining largeportions of the cortex. Recent attempts to select small-
er, more local veins (Fan et al., 2012) require manual selection of voxels
which are entirely intravascular, which is potentially subject to observer
error or bias. An alternative approach using susceptibility mapping was
recently proposed, which exploits intravascular and extravascular phase
data to estimate the tissue–vein susceptibility difference and measure
Yv in smaller veins (Haacke et al., 2010). However, this approach also po-
tentially has the same partial voluming effects.
Alternatively, Yv can be measured by exploiting the effect of dHb on
the transverse relaxation rate of blood, T2,blood. Measurements of T2,blood
in the superior sagittal sinus have been used to estimate global Yv (Oja
et al., 1999; Lu and Ge, 2008; Jain et al., 2013), whilst Yv has been
mapped using T2 measurements in which velocity encoding has been
applied to select the venous blood signal and suppress static tissue
(Bolar et al., 2011; Guo and Wong, 2012). These approaches require
prior calibration to estimate Yv from T2,blood, based on in-vitro T2 mea-
surements made on blood samples over a range of Yv and Hct values.
Gradient-echo sampling of spin-echo (GESSE) has also been used to
map Yv (He and Yablonskiy, 2007), where the shape of the sampled
transverse relaxation curve is dependent on both oxygen extraction
fraction (OEF) and cerebral blood volume (CBV), though this requires
ﬁtting of the data to a complex model to disentangle OEF from CBV.
More recently, an alternativemethod has been proposedwhich builds
on calibrated BOLD methodology (Bulte et al., 2012; Gauthier and Hoge,
2012; Wise et al., 2013). Hypercapnia (Davis et al., 1998) and hyperoxia
(Chiarelli et al., 2007) calibration models are combined to map OEF
(and hence Yv) based on measurements of BOLD and CBF in response to
hypercapnia and hyperoxia. This approach is time consuming since
these measurements are needed at hypercapnia, hyperoxia and
normocapnic normoxia.
In this study we compare three methods of calculating Yv using MR
phasemeasures.Method I: the existing approachwhich assumes the in-
ﬁnite cylinder approximation for a vein that is approximately parallel to
B0, this provides an estimate of Yv by considering the ﬁeld shift inside a
large vein, here taken to be the superior sagittal sinus.Method II: over-
comes any assumption about the shape and orientation of the vein by
using a forward ﬁeld calculation (Marques and Bowtell, 2005) of the in-
travascular ﬁeld perturbation based on the actual shape of the vein.
Method III: the change in intra and perivascular phase distribution to a
known change in Yv on hyperoxia is used to calculate Yv on normoxia.
Since this approach does not require amodel of the expected intra or ex-
travascular phase distribution (from the forwardmodel or inﬁnite cylin-
der model), it is suitable for veins of any shape and orientation, and can
be applied to smaller veins as it is not biased by partial voluming. There-
fore, this method could be applied to measure Yv in local veins, as ap-
posed to providing just a global measurement.
Methods
Eight healthy volunteers (7 male, 1 female; age range 22–32 years)
participated in this study. Ethical approval was given by the University
of Nottingham Medical School Ethics Committee and all subjects gave
informed written consent prior to participating. Scanning was per-
formed on a Philips Achieva 7 T system, with a head volume transmit
coil and 32 channel head receive coil. Whole-head, ﬂow-compensated,3D FLASH data (TE/TR = 5/9.5 ms, SENSE = 2.25 (AP)) were acquired
at 0.65 mm isotropic resolution (208 × 208 × 100 mm FOV) in
3.5 min. In six subjects, 3D FLASH data was collected at both normoxia
and hyperoxia. Details of the respiratory paradigm are provided in
Section Respiratory paradigm. In a further two subjects, the reproduc-
ibility of the estimate of Yv from intravascular measurements was
assessed by repeating the 3D FLASHacquisitionmultiple times (6 repeats
for the ﬁrst subject, 7 repeats for the second subject, each repeat separat-
ed by a 2 min pause), with the subject breathing room air. The numbers
of repeats were determined by the total time that the subject felt that
they could comfortably remain still. In addition, for all subjects a multi-
echo 3D FLASH dataset was acquired at normoxia, comprising 3 echoes
at TE = 5/10/15 ms, TR = 21 ms, SENSE = 2.25 (AP)/1.4 (FH), with
the same spatial resolution and coverage to allow identiﬁcation of veins.
Respiratory paradigm
A feed-forward, lowgasﬂowsystem (RespirAct™, Thornhill Research
Inc., Toronto, Canada) and a sequential gas delivery (SGD) breathing cir-
cuit (Banzett et al., 2000; Slessarev et al., 2007) were used to target end-
tidal PCO2 (PETCO2) and PO2 (PETO2) independently (Slessarev et al.,
2007). Source gases used by the systemwere O2, air, and two gas blends
of N2, CO2 and O2, so that all source gases contained safe concentrations
of O2. The RespirAct™ uses the approach of Slessarev et al. (2007) to cal-
culate the required ﬂows of these source gases into the SGD breathing
circuit to attain the targeted PETCO2 and PETO2 values. For the normoxia
condition, both PETO2 and PETCO2 were maintained at the subject's rest-
ing values (~110 mm Hg and ~40 mm Hg, respectively). For the
hyperoxia condition, PETO2 was targeted at 500 mm Hg, whilst PETCO2
was maintained at the resting value.
Analysis
A complex 2D Hanning spatial ﬁlter was used to high-pass ﬁlter the
phase data (Wang et al., 2000). Whilst both Hanning ﬁltering
(Fernandez-Seara et al., 2006; Fan et al., 2012) and polynomial ﬁtting
(Jain et al., 2010) techniques have been used previously to remove large
scale phase inhomogeneities at lower ﬁeld strengths, the polynomial
ﬁtting approach lacked sufﬁcient ﬂexibility to accurately account for the
greater inhomogeneities found at 7 T. Three ﬁlter sizes were compared,
with the Hanning ﬁlter kernel diameters of D = 16, 32 and 64 pixels in
k-space, respectively. Fig. 1 shows the results of applying each of theseﬁl-
ter sizes to phase data collected at normoxia. The spatial ﬁlter removes
large-scale phase changes due to external sources and is particularly rel-
evant for data collected at hyperoxia, where increased oxygen in the
oral cavity and frontal sinus leads to an increased ﬁeld inhomogeneity
across the brain (Pilkinton et al., 2011). Therefore, the ﬁnest ﬁlter (D =
64) was applied to both hyperoxia and normoxia phase data forMethod
III. For each single echo 3D FLASH dataset, the magnitude data were reg-
istered to the ﬁrst echo magnitude image of the multi-echo 3D FLASH
dataset, using FLIRT (FSL, fMRIB, Oxford, UK) and the resulting transfor-
mations applied to the corresponding ﬁltered phase data.
Measurement of Yv using intravascular phase (Methods I and II)
Yv was calculated based on the phase shift (ΔϕIV) between the sur-
rounding tissue and the vein, which was converted to a ﬁeld shift
(ΔB) using
ΔB ¼ ΔϕIV
γ  TE ; ð1Þ
where γ is the proton gyromagnetic ratio and TE is the echo time. The
susceptibility shift (ΔχIV) of the vein relative to the surrounding tissue
was calculated from ΔB, using
ΔB ¼ A  B0  ΔχIV; ð2Þ
Fig. 1. Example normoxia phase data after spatial ﬁltering with a complex Hanning ﬁlter diameter of D = 16, D = 32 and D = 64 pixels in k-space.
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ometry which was calculated in two ways, as described in
Sections Method I: inﬁnite cylinder approximation and Method II:
forward ﬁeld calculation. ΔχIV is related to Yv by
ΔχIV ¼ Hct  1−YVð Þ  Δχdo; ð3Þ
where Hct is haematocrit (Hct = 0.4 assumed here), and Δχdo =
3.32 × 10−6 (SI units, 0.264×10−6 in cgs units) is the volume suscepti-
bility difference between fully deoxygenated and fully oxygenated
haemoglobin (Spees et al., 2001; Jain et al., 2012). Eq. (3) is based on
the assumption that tissue has a similar susceptibility to fully oxygenat-
ed haemoglobin, as has been assumed in previous MR-susceptometry
studies of blood oxygenation (Haacke et al., 1997; Fernandez-Seara
et al., 2006; Jain et al., 2010; Fan et al., 2012). Thus Yv can be estimated
from
YV ¼ 1−
ΔϕIV
A  γ  TE  B0 Hct  Δχdo
: ð4Þ
To calculate ΔϕIV inMethods I and II, the difference in ﬁltered phase
was found between an intravascular region of interest (ROI) within the
superior sagittal sinus and a local reference ROI in tissue, as illustrated in
Fig. 2. A sagittal sinus ROI was drawnmanually around the sinus on the
ﬁrst echo magnitude image of the multi-echo dataset, extending from
the conﬂuence of sinuses to the point at which the sinus curves to ap-
proximately 30° from the B0 direction. This sagittal sinus ROI was also
required for the forward ﬁeld calculation described in Section Method
II: forward ﬁeld calculation. A 30° limit was chosen ﬁrstly to provide a
repeatable boundary for the ROI, and secondly since the inﬁnite cylinder
approach has been shown to be a reasonable approximation up to tilt
angles of 30° (Li et al., 2012). Five slices were selected, where the sagit-
tal sinus was approximately parallel to B0. An intravascular ROI wasFig. 2.Example intravascular (red) and reference (blue) ROI, based on themanually drawn
sagittal sinus ROI (green).formed by eroding the sagittal sinus ROI by one voxel (3 × 3 kernel)
over these 5 slices. A reference ROI (a ring of tissue surrounding the sag-
ittal sinus) was formed by ﬁrst dilating the sagittal sinus ROI by two
voxels (5 × 5 kernel) and then subtracting the sagittal sinus ROI dilated
by one voxel (3× 3 kernel). To avoid edge artefacts caused by the spatial
ﬁlter, these ROIs were constrained by applying a whole brain mask
(formed using BET (FSL)) eroded by 3 voxels (7 × 7 kernel). ΔϕIV was
calculated from the difference in the average ﬁltered phase data be-
tween the intravascular and reference ROIs.
Method I: inﬁnite cylinder approximation. The inﬁnite cylinder approxi-
mation (Method I) assumes that the vein is straight over the region of in-
terest and that the length of the vein is much greater than its diameter.
In this case, the scaling factor A in Eq. (4) is given by
A ¼
3 cos2θ−1
 
6
; ð5Þ
where θ is the angle of the cylinder's long axis relative to the direction of
B0. A section of the sagittal sinus which was parallel to B0 (θ= 0) was
chosen, such that A= 1/3, providing maximal ΔϕIV. The extravascular
phase distribution is close to zero where the sagittal sinus is parallel to
B0, minimising any contribution to the local reference ROI.
Method II: forward ﬁeld calculation. The second approach (Method II)
uses a forward ﬁeld calculation (Marques and Bowtell, 2005) which
takes account of the exact shape of the superior sagittal sinus (SSS), as
illustrated in Fig. 3. An ROI was drawn around the superior sagittal
sinus, from the conﬂuence of sinuses to where the sinus curves to ap-
proximately 30° away from the B0 direction, based on the ﬁrst-echo
magnitude image of the multi-echo dataset. This was then used to
form a susceptibility map, with unit susceptibility difference between
the ROI and elsewhere. The forward ﬁeld calculation employs a discrete
Fourier transform, so a largematrix sizewas used to ensure that aliasing
artefacts wereminimised and located at the edge of the padded matrix,
away from the area of interest around the sagittal sinus ROI (Marques
and Bowtell, 2005). The ROI may be located off centre in the original
image, so the original matrix was included in the padded matrix to pre-
vent discontinuities when unpadding (i.e. returning to the original
image space), which would affect spatial ﬁltering (detailed below).
Therefore the matrix containing the sagittal sinus ROI mask was zero-
padded to an N × N × N matrix, centred on the ROI, where N was at
least twice the length of the ROI, and included the entire original
image matrix.
The forward ﬁeld calculation in k-space was used to estimate the
ﬁeld in the vessel. A 3D discrete fast Fourier transform (MATLAB, The
Fig. 3. The analysis steps for the forwardﬁeld calculation. Amanually drawn superior sagittal
sinus (SSS) binarymask (b, green ROI) is used to form a ﬁeld perturbationmap (c), which is
then spatial ﬁltered (d) using the sameﬁlter as applied to the phase data (a). The intravascu-
lar (red) and reference (blue) ROIs in (d) are the same as in Fig. 2.
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ﬁeld perturbation calculated based on Eq. (6) in Marques and Bowtell
(2005), and then an inverse 3D discrete fast Fourier transformwas per-
formed. The orientation of the matrix with respect to B0 is required in
the calculation, which was found by combining the angles recorded
when planning the scan geometry with the transformations applied to
register the image to the multi-echo data.
The resulting ﬁeld perturbation map was unpadded, so as to be
aligned with the original image. The spatial ﬁlter applied to the phase
data (see above) was also applied to this ﬁeld perturbationmap. The ﬁl-
tered map was then used to calculate the scaling factor A, as the differ-
ence in ﬁeld perturbation between the sagittal sinus and the
surrounding tissue based onΔχ=1,which is then used in Eq. (4) to cal-
culate Δχ.Method III: measurement of Yv using hyperoxia intra and perivascular
phase contrast
Since haemoglobin in arterial blood is close to having full oxygen
saturation at normoxia, the extra arterial oxygen that is present on
hyperoxia is dissolved in blood plasma. When blood enters the capil-
laries, dissolved oxygen is taken up into cerebral tissue as readily as
that bound to haemoglobin, so Yv is increased. The change in Yv on
hyperoxia was calculated using an existingmodel, see below. Therefore
a controlled level of hyperoxiawas used to generate a controlled change
in Yv, to perturb the amplitude of the phase distribution generated by
venous dHb.
This method assumes that the phase distribution in and around a
vessel at normoxia is dominated by the effect of intravascular dHb and
thus provides a template for the phase change on hyperoxia due to a
change in Yv. This is an extension and simpliﬁcation of the method
that we recently introduced to measure Yv at normoxia (Driver et al.,
2012). Thus, the hyperoxia phase distribution (ϕHO(r)) was ﬁtted to
the normoxia phase distribution (ϕNO(r)), according to
ϕHO rð Þ ¼ a  ϕNO rð Þ þ k; ð6Þ
where a is the ﬁtting parameter and the subscripts HO and NO refer to
hyperoxia and normoxia, respectively. A conventional linear least-
squares minimisation approach was not appropriate in this case, since
both coordinates (ΔϕHO and ΔϕNO) have associated errors. awas there-
fore found byusing York's solution to a linear least-squaresﬁtwith errors
in both coordinates (Reed, 1989, 1992). This linear ﬁtting approach can
ﬁt the gradient (a) independently of the intercept (k), so any non-local
phase offsets between ϕHO and ϕNO will not introduce bias (in the limit
where the offset is constant across the ROI). Thus, assuming that the
phase distribution in the ROI is dominated by the susceptibility of the
vein,
a ¼ ΔχHO
ΔχNO
; ð7Þ
where Δχ is the susceptibility difference between the vein and the sur-
rounding tissue. This equation makes no assumptions about the spatial
nature of the ﬁeld shift around the vein. Assuming that tissue has the
same susceptibility as fully oxygenated haemoglobin, Δχ can be related
to Yv by
ΔχNO ¼ Hct  1−YVð Þ  Δχdo; ð8Þ
ΔχHO ¼ Hct  1−YV−ΔYhð Þ  Δχdo; ð9Þ
where ΔYh is the change in venous blood oxygenation due to hyperoxia.
Eqs. (8) and (9) can be substituted into Eq. (7) and rearranged to give
YV ¼ 1−
ΔYh
1−að Þ : ð10Þ
ϕ(r) was assessed over an ROI selected as follows. The multi-echo
magnitude data were combined into an R2* map using a voxel-wise lin-
ear regression (MATLAB). Veinswere identiﬁed by applying a threshold
of R2* N 100 s−1. Additionally, the whole-brain mask, eroded by
5 voxels (11 × 11 kernel), was applied to exclude voxels close to the
edge of the brain due to edge artefacts from the spatial ﬁlter. Individual
veinswere indexed by clustering the binary thresholdedmap (convolu-
tion with a 3 × 3 × 3 kernel). This segmentation method often included
the inter-hemispheric ﬁssure, so this was excluded by removing any
clusters which included 1200 or more voxels. An ROI was deﬁned for
each vein by dilating the binarymap by one voxel (using a 3 × 3× 3 ker-
nel). This approach was found to be optimal for small veins, where it
covered the majority of the vein's phase distribution, without including
a signiﬁcant number of voxels where Δϕ dropped into the noise.
Table 1
Individual subject Yv values in the sagittal sinus forMethod I (inﬁnite cylinder approxima-
tion) andMethod II (forward ﬁeld calculation), results are shown for the D = 16 ﬁlter.
Individual subject Yv values
Method I
(sagittal sinus)
Method II
(sagittal sinus)
Method IIIa
(averaged over small veins)
0.712 0.705 0.652
0.620 0.582 0.666
0.682 0.644 0.647
0.678 0.654 0.687
0.651 0.622 0.638
0.581 0.490 0.676
0.607 ± 0.015b 0.545 ± 0.017b
0.728 ± 0.020b 0.697 ± 0.023b
0.66 ± 0.05c 0.62 ± 0.07c 0.66 ± 0.02c
a Mode across veins shown forMethod III (using hyperoxia phase contrast).
b The two reproducibility subjects are marked with (mean ± SD across repeats).
c Mean ± SD Yv across subjects.
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PETO2 measurements into ΔYh, assuming that arterial PO2 (PaO2) can
be approximated by PETO2 (i.e. PaO2 = PETO2). Whilst this assumption
is not generally true, it is reasonable for the gas delivery method used
here (see Estimating qh section of Driver et al. (2012)). Assuming that
the amount of oxygen extracted from the capillaries is constant be-
tween normoxia and hyperoxia, then
ΔYh ¼
ψ  Hb½   ΔSaO2 þ ε  ΔPaO2
ψ  Hb½  ; ð11Þ
adapted from Eq. (11) in Driver et al. (2012), where ψ=1.34ml (O2)/g
is the oxygen carrying capacity of haemoglobin, [Hb] = 15 g/dlblood is
the concentration of haemoglobin and ε= 0.0031 ml/dlblood/mm Hg
is the solubility coefﬁcient of oxygen in blood (values obtained from
Chiarelli et al. (2007)). ΔPaO2 is the difference in PaO2 between
hyperoxia and normoxia, whilst ΔSaO2 is the difference in arterial
haemoglobin oxygen saturation (SaO2) between hyperoxia and
normoxia. SaO2 was calculated at hyperoxia and normoxia from PaO2,
based on the oxygen dissociation in blood, described by awidely accept-
ed model (Severinghaus, 1979):
SaO2 ¼
23400
PaO32 þ 150PaO2
−1
 !−1
: ð12Þ
Results
Intravascular measurement of Yv (Methods I and II)
Measurements of Yv in the superior sagittal sinus for each of the three
Hanningﬁlter diameters (D=16, 32 and 64) are shown in Fig. 4, for both
the inﬁnite cylinder (Method I) and forward ﬁeld calculation (Method II)
approaches.Whilst the use of the ﬁner spatial ﬁlter (D=64) inMethod I
leads to an overestimation of Yv (due to theﬁlter being of a similar length
scale to the size of the superior sagittal sinus), this overestimation was
much smaller forMethod II. The value of Yv calculated using the forward
ﬁeld calculation was less than that found from the inﬁnite cylinder ap-
proximation, due to the value of A being less than 1/3 in every instance
(each ﬁlter size for each subject). For example, A = 0.303 ± 0.006
(mean ± SEM, 8 subjects) for the D = 16 ﬁlter. Individual subject Yv
values are shown in Table 1 for the D = 16 ﬁlter, with mean Yv values
of 0.66 ± 0.05 forMethod I and 0.62 ± 0.07 forMethod II (mean ± SD,
8 subjects).
The coefﬁcient of variation (CoV) in the estimate of Yv was calculat-
ed for the reproducibility data. For the forward ﬁeld calculationwith the
D= 16 ﬁlter, a CoV of 3.0% and 3.4% was found for each of the two sub-
jects. Similar CoVs were found for the D = 32 and D = 64 ﬁlters andFig. 4.Mean Yv across subjects (SEM error bars) based on intravascular phase after spatial
ﬁltering with each of the three different complex Hanning ﬁlter widths. Results based on
the inﬁnite cylinder approximation (Method I) are shown in black and the forward ﬁeld
calculation (Method II) is shown in grey.between the forward ﬁeld calculation and inﬁnite cylinder approaches
(CoV range 1.5–3.6%).
Measurement of Yv using hyperoxia phase contrast (Method III)
PETO2 increased by 320±20mmHg (mean±SEM, 6 subjects), lead-
ing to a calculated increase in venous blood oxygenation of ΔYh =
0.066 ± 0.003. It is worth noting that the hyperoxia was not accompa-
nied by signiﬁcant hypocapnia; average PETCO2 was 38.9 ± 1.0 mm Hg
at normoxia and 38.6 ± 1.3 mm Hg at hyperoxia (both mean ± SEM
across subjects), with the change between normoxia and hyperoxia
ranging from +1.21 to−1.69 mm Hg (increase in 2 subjects/decrease
in 4 subjects).
Fig. 5a shows an example map of Yv calculated for each detectable
vein, overlaid on the normoxia phase image. Note that due to the simple
clustering algorithm, a small number of veins were selected in a cluster
in the inter-hemispheric ﬁssure. Therefore Yv was not calculated for
these veins. The distribution of Yv values across all veins in all 6 subjects
is shown in a histogram in Fig. 5b, since the data is not normally distrib-
uted, the estimate of Yv in each subject was characterized by the mode
of the distribution. Individual subject Yv modes are shown in Table 1,
with the mean of these individual subject values being Yv = 0.66 ±
0.02 (mean ± SD, 6 subjects).
Monte Carlo simulationswere performed to assess the effect of noise
propagation from the ﬁt for a into the Yv calculation (Eq. (10)). 10,000
pairs of normoxia and hyperoxia phase distributions with the same
order of SNR (=20) as the actual data in an ROI of 200 voxels were sim-
ulated. An example of these simulations for a value of Yv = 0.66 is
shown in Fig. 5b (white histogram), demonstrating good precision in
the calculated value of Yv, but a slight skew towards smaller Yv values
due to the noise propagation through the reciprocal relationship de-
scribed in Eq. (10). This skew was found to increase at lower Yv values
and is also seen in the real data (blue histogram). The real data has a
larger variance than the simulated data, partly due to variation in the
sizes of ROIs used in the realﬁts, and also due to expected heterogeneity
in Yv between veins and between subjects.
There was no signiﬁcant difference in the results from the three
methods (p = 0.3 single effect ANOVA) when the D = 16 ﬁlter was
used forMethods I and II.
Discussion
In this study we compare three approaches for measuring venous
blood oxygenation based on mapping the phase distribution caused by
deoxyhaemoglobin in the vein. The intravascular phase in the superior
sagittal sinus was used to calculate Yv, either using an inﬁnite cylinder
approximation (Method I) or a forward ﬁeld calculation using the actual
Fig. 5.Results for thehyperoxia phase contrastmethod (Method III). (a) Single subjectmap
of Yv, overlaid on the ﬁltered (D = 64) normoxia phase data. Sagittal and axial slices are
shown, whilst the green line shows the location of the slice position of the other orienta-
tion. (b) Histogram showing Yv values for each vein across all subjects, where each vein is
weightedby thenumber of voxels in that vein (blue histogram, left axis).Monte Carlo sim-
ulation results of this method are also shown (white histogram, right axis).
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new approach for mapping Yv based on measuring the change in the
phase distribution around small veins on hyperoxia is demonstrated
(Method III). There was no signiﬁcant difference in Yv measured from
the three methods (considering the coarsest spatial ﬁlter was used for
Methods I and II), as assessed by a 1-way ANOVA, although it should
be noted that Methods I and II had larger inter-subject variance in Yv
compared toMethod III.
However there was a marked trend forMethod I to measure larger
values of Yv thanMethod II. This is expected since the forward ﬁeld cal-
culation (Method II) captures individual variations in the shape and ori-
entation of each subject's sagittal sinus, unlike the inﬁnite cylinder
approach. As a result, in the forward ﬁeld calculation the scaling factor
A was consistently found to be less than 1/3 (the value assumed for
the inﬁnite cylinder approximation:Method I), leading to smaller esti-
mated values of Yv. On the other hand there is a human error associated
withmanually drawing around the sagittal sinus and hence the forward
ﬁeld calculationmethod ismore labour intensive than the inﬁnite cylin-
der approach. Spatial ﬁltering may also be expected to affect the two
methods differently. The choice of spatial ﬁlter is particularly important
when considering large veins, since ﬁner spatial ﬁlters will reduce the
vein–tissue phase difference when the ﬁlter length scale is similar to
the size of the vein, causing an overestimation in Yv (Langham et al.,
2009). However the effect of the ﬁltering is somewhat overcome in
Method II since the forward ﬁeld calculation maps are also ﬁltered.This was conﬁrmed by the relative stability of Yv measurements across
ﬁlter size for Method II compared to Method I. Therefore on balance it
is expected that Method II will be more accurate than Method I,
although cross-validation with an independent technique is required
to conﬁrm this.
The method for selecting a reference ROI for Methods I and II was
chosen to be reproducible across subjects and to ensure that the refer-
ence ROIwas local to the intravascular ROI. On visual inspection this ref-
erence ROI did not appear to overlap with the extravascular ﬁeld
surrounding the sagittal sinus. A distance of approximately 5 mm be-
tween intravascular and reference regions has been used previously
compared to 1.95 mm used here (Li et al., 2012). In future work it
would be useful to investigate the effect of varying the position of the
reference ROI. ForMethod I, as well as being orientated approximately
parallel to the static magnetic ﬁeld, the portion of the sagittal sinus to
be investigated should also be fairly straight, to maximise the accuracy
of the inﬁnite cylinder approximation.
In this work we have assumed that tissue has a similar susceptibility
to fully oxygenated haemoglobin, an approach taken previously. Studies
measuring the susceptibility difference Δχdo suggest that fully oxygen-
ated haemoglobin is slightly diamagnetic relative to water (Weisskoff
and Kiihne, 1992; Spees et al., 2001; Jain et al., 2012). Tissue susceptibil-
ity is difﬁcult to measure and is likely to vary across brain regions and
subjects. The effect of removing the assumption of tissue susceptibility
being equal to that of fully oxygenated haemoglobin will introduce an
extra term (+Hct · Yv · Δχoxy) into Eq. (3) and equivalent terms in
Eqs. (8) and (9), where Δχoxy is the susceptibility difference between
fully oxygenated haemoglobin and tissue. These lead to an additional
term +Δχoxy / Δχdo in Eqs. (4) and (10). For example, using the value
of Δχoxy = −0.21 × 10−6 (SI units, or −0.017×10−6 in cgs units)
based on the susceptibility difference between water and fully oxygen-
ated haemoglobin (Spees et al., 2001), the value for Yv would be 0.06
smaller if tissue susceptibility were equal to that of water, as opposed
to that of fully oxygenated haemoglobin. This is expected to be an
upper limit on any systematic error in Yv, since tissue is also likely to
be slightly diamagnetic relative to water due to the presence of myelin
(Liu et al., 2011; Lee et al., 2012; Wharton and Bowtell, 2012).
The use of an assumed value for Hct could lead to a systematic error
in Yv, especially when studying pathologies where Hct may be
perturbed. This limitation is not restricted to susceptometry-based
methods, but is also true for the other MRI-based oximetry techniques
mentioned in the Introduction section. This limitation can be overcome
through directmeasurement of Hct from blood samples, although some
variations through the circulatory system may remain (Yang et al.,
2001; Baskurt et al., 2006).
Whilst the intravascularmethods (Methods I and II) can only be used
on large veins, whose size, shape and orientation can be clearly deter-
mined, the hyperoxia-based method (Method III) uses the normoxia
phase distribution as a model of the pattern of phase change expected
on hyperoxia. Since the phase distribution of a vein extends into the sur-
rounding tissue, Yv can be mapped from veins whose diameters are
smaller than the voxel size, and voxels that are partially intravascular
and partially extravascular do not have to be discarded, as they do for
the intravascular methods (Methods I and II). Whilst a simple, automat-
ed approach was used here for vein identiﬁcation and for ﬁtting the
phase distribution in hyperoxia to the normoxia phase distribution, in
the future, more sophisticated techniques could improve speciﬁcity.
For example, in this work the broad range of veins selected meant that
the ROI selection was not optimal for every vein investigated, whereas
a more targeted study of speciﬁc veins, with the ROI selection individu-
ally optimised to the speciﬁc extent of the vein's ﬁeld distribution,
would achieve an improved SNR in Yv.
The results from Method III cannot be directly compared with
Methods I and II since the hyperoxia contrast method was not applied
in the superior sagittal sinus due to the use of extravascular signal and
the proximity of the sagittal sinus to edge artefacts arising from spatial
464 I.D. Driver et al. / NeuroImage 101 (2014) 458–465ﬁltering. Whilst small residual contributions from edge artefacts have
little effect on the absolute IV phase measurements inMethods I and II,
Method III considers small changes in the phase distribution, which are
more sensitive to bias induced by these edge artefacts whichmay differ
between normoxia and hyperoxia phase images. Further work is re-
quired to overcome this limitation. Nonetheless there was a trend for
Method III to measure higher oxygenation than Method II, as might be
expected in these smaller veins.
Care must be taken with image registration when mapping the
hyperoxia phase distribution onto the normoxia phase distribution. Sig-
niﬁcant rotations will change the vein orientation with respect to B0,
changing the phase distribution. For this study, the maximum rotation
between normoxia and hyperoxia scans was less than 4° with respect
to B0 and less than 1° in the plane perpendicular to B0, so it was consid-
ered to have an insigniﬁcant effect on the phase distribution.
The hyperoxia-based method assumes that cerebral blood volume
(CBV), cerebral blood ﬂow (CBF) and cerebral metabolic rate of oxygen
consumption (CMRO2) remain constant between the normoxia and
hyperoxia scans. This is important since changes in these parameters
will affectΔYh, introducing a bias into Yv (propagating linearly, according
to Eq. (10)). CBV and CBF can be maintained during hyperoxia by
employing isocapnic hyperoxia (Croal et al., 2012) to prevent systematic
changes in arterial CO2 concentrations (CO2 is a potent vasodilatory stim-
ulus). An isocapnic gas challenge can either be presented using the pro-
spective method that we use here (Slessarev et al., 2007), or by
dynamic end-tidal forcing (Wise et al., 2007). Whilst previous calibrated
BOLD studies have assumed constant CBV, CBF and CMRO2 on isocapnic
hyperoxia (Mark et al., 2011; Driver et al., 2012), recent work (Xu et al.,
2012)measured a decrease in CMRO2with hyperoxia. However, it should
be noted that their study preceded a hyperoxia condition with a hypoxia
condition, and thismayhave affected the results since it is known that ce-
rebral lactate concentrations remain elevated for more than 10 min after
the end of a hypoxia challenge (Harris et al., 2013).
The hyperoxia-based method for measuring Yv uses a model to esti-
mate a value of ΔYh from measured PETO2, as we proposed previously
(Driver et al., 2012). This model is adapted from that used for
hyperoxia-based calibrated BOLD experiments (Chiarelli et al., 2007).
By calculating absolute, rather than relative changes in Yv, the model
is independent of OEF. A single value of ΔYh is assumed across the
whole brain for each subject, which is reasonable since arterial blood
oxygenation should be homogeneous across brain regions. The method
is insensitive to local variations in oxygen extraction, so long as oxygen
extraction does not change between normoxia and hyperoxia.
Another assumption used in Method III is that tissue susceptibility
does not change due to hyperoxia, whereas in practice any changes in
tissue PO2 will change the tissue susceptibility and the vein–tissue
susceptibility difference. Tissue PO2 can be estimated based onmeasured
PETO2 and an assumed normoxia OEF value (Schwarzbauer and
Deichmann, 2012). The change in tissue PO2 (ΔPtO2) decreases with in-
creasing normoxic OEF. Based on a PETO2 change from110 to 500mmHg
(approximate targets for this study), ΔPtO2 = 61.5 mm Hg will occur
when a lowOEF of 0.3 is assumed. This would cause an increase in tissue
susceptibility Δχ= 3.3 × 10−9 (SI units), which is more than 30 times
less than the vein susceptibility Δχ due to ΔYh. Smaller tissue Δχ values
will occur for higher normoxic OEF values (e.g. Δχ= 2.6 × 10−9 for an
OEF of 0.4), so this will have an insigniﬁcant effect on the value of Yv
measured.
In conclusion, the intravascular phase approach based on an inﬁnite
cylinder approximation is the simplest to implement and can be per-
formed on a single 2D slice (minimising acquisition times), however it
is the most susceptible to the effects of the spatial ﬁlter removing
phase contrast. Yv measurements made using the intravascular phase
approach based on a forward ﬁeld calculation are less sensitive to the
spatial ﬁlter, however this approach is more user intensive, as the
shape of the vein must be mapped out. Both of these intravascular
phase approaches require the vein of interest to be sufﬁciently largethat intravascular voxels that are free from partial voluming can be se-
lected. These methods also require assumptions to be made as to the
shape of the phase distribution, involving knowledge of the vein's size,
shape and orientation. The hyperoxia phase contrast-based approach
provides a measurement of Yv that does not require any prior knowl-
edge of the vein's geometry, instead it compares maps of the hyperoxia
phase distribution with those of the normoxia phase distribution.
Whilst this method requires the delivery of isocapnic hyperoxia, it
shows promise in allowing the measurement of Yv in smaller veins,
which would be susceptible to partial volume issues when using other
phase-based approaches, thus allowing the study of regional variations
in OEF.
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